×
Please click
here
if you are not redirected within a few seconds.
All
Images
News
Videos
Maps
Shopping
Books
Search tools
Recent
Recent
Past hour
Past 24 hours
Past week
Past month
Past year
Archives
Sorted by relevance
Sorted by relevance
Sorted by date
Vertex Pharmaceuticals (VRTX) Falls More Steeply Than Broader Market: What Investors Need to Know
Yahoo Finance
Vertex Pharmaceuticals (VRTX) closed the most recent trading day at $397.70, moving -0.76% from the previous trading session.
1 day ago
As pharma eyes shiny obesity drugs, Vertex tops orphan drug list
Fierce Biotech
Vertex's cystic fibrosis triple combo is the top orphan pipeline drug, amid shifting sentiments in the pharma industry for rare disease...
3 days ago
(VRTX) - Analyzing Vertex Pharmaceuticals's Short Interest - Vertex Pharmaceuticals (NASDAQ:VRTX)
Benzinga
Vertex Pharmaceuticals's. VRTX. short percent of float has fallen 3.75% since its last report. The company recently reported that it has...
1 day ago
Vertex AI Price Forecast: Bitcoin Has 60% Chance Of Hitting $100000, Key Predictions Unveiled
www.tradingview.com
On-chain analytics firm Spot On Chain's team of analysts, using Google Cloud's Vertex artificial intelligence (AI), has conducted an...
1 day ago
Vertex jumps to TreeFrog to enhance production of Type 1 diabetes cell therapy candidates
Fierce Pharma
Helping Vertex develop three pipeline candidates in Type 1 diabetes will be French cell therapy developer and manufacturer TreeFrog...
2 days ago
Vertex offers limited access to a cystic fibrosis drug in South Africa — and may undercut a court case
STAT
After months of sustained criticism, Vertex Pharmaceuticals reached an agreement to provide a pricey cystic fibrosis treatment in South...
1 day ago
The Zacks Analyst Blog Highlights Biogen, Bristol Myers Squibb, Incyte and Vertex Pharmaceuticals
Yahoo Finance
Biogen, Bristol Myers Squibb, Incyte and Vertex Pharmaceuticals are part of the Zacks top Analyst Blog.
17 hours ago
Vertex, Inc. Announces Closing of Upsized Offering of $345 Million Convertible Senior Notes
Yahoo Finance
KING OF PRUSSIA, Pa., April 26, 2024 (GLOBE NEWSWIRE) -- Vertex, Inc. (NASDAQ: VERX) (“Vertex”), a leading global provider of indirect tax...
8 hours ago
Vertex Pharmaceuticals Nabs Alpine Immune Sciences In $4.9 Billion Deal
Investor's Business Daily
Vertex Pharmaceuticals will pay $4.9 billion to acquire Alpine Immune Sciences. Alpine stock rocketed almost 21% on rumors of the deal.
2 weeks ago
South Africans take on big pharma for access to ‘miracle’ cystic fibrosis drug
The Guardian
Cheri Nel cannot afford Vertex's Trikafta medicine, so she is suing to end 'patent abuse' and allow a generic version.
1 month ago